Zimmer Biomet Holdings, Inc (ZBH) Stock Analysis
Verdict: WATCH (do not buy)
ZBH is a high-margin cash fortress executing a 'tuck-in' M&A strategy, but technical weakness and soft top-line growth limit near-term upside.
Investment score: 58/100
Analysis as of
Is Zimmer Biomet Holdings, Inc stock worth reviewing? AI model thesis
The model views ZBH as an undervalued medical device leader with superior margins (70%) compared to peers like BDX (46.5%). While recent M&A and digital surgery tailwinds are positive, the technical price action and recent insider selling (Yi Sang) warrant caution. The AI model prefers waiting for price stabilization above the 52W low of $79.12 before initiating a position.
7-factor investment score
- Valuation: 72/100 (weight 20%)
- Financial Health: 55/100 (weight 15%)
- Technical Momentum: 35/100 (weight 15%)
- Earnings Quality: 75/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 52/100 (weight 10%)
- Risk-Adjusted Return: 60/100 (weight 15%)
Zimmer Biomet Holdings, Inc opportunities and risks
What speaks for ZBH
- High Free Cash Flow Generation
What speaks against ZBH
- Intense MedTech Competition
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| ZBH | 21.9x | 1.9x | 10.6x | 70.0% | 9.1% | 11.2% |
| BDX | 38.4x | 2.6x | 15.3x | 46.5% | 5.3% | 5.7% |
| IDXX | 38.1x | 9.2x | 27.0x | 62.1% | 24.6% | 2.6% |
| GEHC | 19.3x | 1.5x | 11.0x | 42.5% | 7.5% | 5.2% |
| RMD | 18.7x | 5.1x | 12.5x | 61.7% | 27.4% | 6.2% |
| DXCM | 28.4x | 5.5x | 18.0x | 61.8% | 19.3% | 5.4% |
| Peer median | 28.4x | 5.1x | 15.3x | 61.7% | 19.3% | 5.4% |
Frequently asked questions about Zimmer Biomet Holdings, Inc (ZBH)
Is ZBH stock a good investment?
The cached TradeMates AI model rates Zimmer Biomet Holdings, Inc as WATCH (do not buy) with an investment score of 58/100. The model views ZBH as an undervalued medical device leader with superior margins (70%) compared to peers like BDX (46.5%). While recent M&A and digital surgery tailwinds are positive, the technical price action and recent insider selling (Yi Sang) warrant caution. The AI model prefers waiting for price stabilization above the 52W low of $79.12 before initiating a position. This is algorithmic model output, not personal investment advice.
Is ZBH stock a buy?
The TradeMates model verdict for ZBH is WATCH (do not buy) with an investment score of 58/100. Treat this as a model signal to review, not a personal buy recommendation.